| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |